Arkolith/Insider Trading/BCRX/Form 4

Stonehouse Jon P

Chief Executive Officer, DirectorBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Dec 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Gift(G)20K—$01.4M
Dec 18, 2025Gift(G)10K—$040K
Dec 18, 2025Gift(G)10K—$040K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-008039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML